Enanta Pharmaceuticals (ENTA) Insider Trading & Ownership $4.93 -0.22 (-4.27%) As of 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Enanta Pharmaceuticals (NASDAQ:ENTA) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.89%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$256,050.00Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$306,026.21 Get ENTA Insider Trade Alerts Want to know when executives and insiders are buying or selling Enanta Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ENTA Insider Buying and Selling by Quarter Remove Ads Enanta Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/12/2025Jay R LulyCEOBuy45,000$5.69$256,050.00 12/6/2024Jay R LulyCEOSell5,142$8.06$41,444.52 12/6/2024Tara Lynn KiefferInsiderSell2,283$8.06$18,400.98 7/15/2024Scott T RottinghausInsiderSell5,375$17.08$91,805.00 7/11/2024Scott T RottinghausInsiderSell4,299$15.07$64,785.93 6/17/2024Tara Lynn KiefferInsiderSell7,266$12.33$89,589.78 (Data available from 1/1/2013 forward) ENTA Insider Trading Activity - Frequently Asked Questions Who is on Enanta Pharmaceuticals's Insider Roster? The list of insiders at Enanta Pharmaceuticals includes Brendan Luu, Jay R Luly, Paul J Mellett, Scott T Rottinghaus, Tara Lynn Kieffer, Terry Vance, and Yat Sun Or. Learn more on insiders at ENTA. What percentage of Enanta Pharmaceuticals stock is owned by insiders? 13.89% of Enanta Pharmaceuticals stock is owned by insiders. Learn more on ENTA's insider holdings. Which Enanta Pharmaceuticals insiders have been buying company stock? The following insider purchased ENTA shares in the last 24 months: Jay R Luly ($256,050.00). How much insider buying is happening at Enanta Pharmaceuticals? Insiders have purchased a total of 45,000 ENTA shares in the last 24 months for a total of $256,050.00 bought. Which Enanta Pharmaceuticals insiders have been selling company stock? The following insiders have sold ENTA shares in the last 24 months: Brendan Luu ($20,463.75), Jay R Luly ($111,069.42), Paul J Mellett ($23,227.56), Scott T Rottinghaus ($161,733.35), Tara Lynn Kieffer ($107,990.76), and Terry Vance ($139,490.40). How much insider selling is happening at Enanta Pharmaceuticals? Insiders have sold a total of 51,961 Enanta Pharmaceuticals shares in the last 24 months for a total of $563,975.24 sold. Enanta Pharmaceuticals Key ExecutivesDr. Jay R. Luly Ph.D. (Age 68)President, CEO & Director Compensation: $1.25MMr. Paul J. Mellett Jr. (Age 69)Chief Financial & Administrative Officer Compensation: $666.84kDr. Yat Sun Or Ph.D. (Age 72)Senior VP of Research & Development and Chief Scientific Officer Compensation: $729.31kMr. Nathaniel S. Gardiner J.D. (Age 70)Consultant Compensation: $672.67kMr. Brendan Luu (Age 49)Chief Business Officer Compensation: $622.86kMs. Jennifer VieraSenior Director of Investor Relations & Corporate CommunicationsMr. Matthew P. Kowalsky J.D. (Age 51)Chief Legal Officer Ms. Tara Lynn Kieffer Ph.D. (Age 46)Chief Product Strategy Officer Compensation: $496.85k1 recent tradesDr. Scott T. Rottinghaus M.D. (Age 50)Senior VP & Chief Medical Officer Compensation: $616.73k More Insider Trading Tools from MarketBeat Related Companies CRMD Insider Trading TYRA Insider Trading PGEN Insider Trading ZVRA Insider Trading RVNC Insider Trading DNA Insider Trading RLAY Insider Trading RAPP Insider Trading ERAS Insider Trading SANA Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Beware of BigBear.ai: Insiders Are Selling—Should You?XPO Buying $50 Million of Its Own Stock: Here's Why Top 3 Large Cap Stocks Insiders Bought in Q1: Buy, Sell, or HoldJoby Aviation: Operational Momentum vs. Market SentimentMicroStrategy Sees Insider Buy-Sell Action in Q1 This page (NASDAQ:ENTA) was last updated on 4/16/2025 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMarkets in Chaos? Here’s What to Do.Wall Street's on edge with tariffs. And volatility? It's not slowing down. You've seen the headlines… Bu...Investors Alley | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enanta Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enanta Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
